Overall Technical outlook

* GLENMARK makes the list of companies with the best fundamentals at present.

Price Summary

On 2026-02-02, Glenmark Pharmaceuticals Limited's stock began at 1935.1, peaked at 1964.4, declined to 1842.0, and ended the day -0.76% down at 1920.4, with 1487549 shares traded.
The stock's highest price in the past 52 weeks is 2226.7, while its lowest price during the same period is 0.0.
The projected price range for Glenmark Pharmaceuticals Limited is between 1500.0 and 2735.0, with an expected mean price of 2198.6667, according to 12 analysts.

Technicals

Support and Resistance: The price of 1920.4 is supported at 1815.1 and encounters resistance at 1940.9. This suggests key levels where the price might find stability, with 1815.1 providing a base and 1940.9 acting as an upper boundary for GLENMARK.
GLENMARK supportResistance c832cf
Support/Resistance for GLENMARK


Aroon: The continuation of Aroon's bearish trend, with Aroon Down still at the 100 level, indicates strong bearish pressure. However, further analysis with additional indicators is essential to better understand the trend's potential impact on the market.
GLENMARK aroon c832cf
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
GLENMARK bbands c832cf
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR has just reversed from bullish to bearish, signaling a potential trend change. If this move is confirmed by other indicators, it could indicate a strong bearish trend. Investors should be cautious and watch for further signs of a market downturn before acting.
GLENMARK psar c832cf
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for Glenmark Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
GLENMARK stoch c832cf
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
GLENMARK trippleSMA c832cf
Tripple SMA chart for Glenmark Pharmaceuticals Limited


Before focusing on a company's technical data, such as stock price movements, it's essential to analyze its fundamentals. These include factors like profitability, cash flow, and debt management. Additionally, considering the broader industry landscape—including market trends, competition, and regulatory changes—offers deeper insights. This comprehensive approach allows for a more meaningful interpretation of the company's technical indicators, providing a clearer picture of its financial health and future prospects.